Temporal Trends in Use of Sildenafil among Pediatric Patients

被引：4

作者：

Bhutta, Adnan T. ^{[1
,2
]}

Beam, Brandon ^{[1
,2
]}

Prodhan, Parthak ^{[1
,2
]}

机构：

[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA

[2] Arkansas Childrens Hosp, Little Rock, AR 72202 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 188卷 / 10期

关键词：

PULMONARY ARTERIAL-HYPERTENSION;

D O I：

10.1164/rccm.201301-0159LE

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1269 / 1271

页数：3

共 6 条

[1] Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension [J].

Abman, Steven H. ;

Kinsella, John P. ;

Rosenzweig, Erika B. ;

Krishnan, Usha ;

Kulik, Thomas ;

Mullen, Mary ;

Wessel, David L. ;

Steinhorn, Robin ;

Adatia, Ian ;

Hanna, Brian ;

Feinstein, Jeffrey ;

Fineman, Jeffrey ;

Raj, Usha ;

Humpl, Tilman .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (06) :572-575

[2]

[Anonymous], 2015, FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood

[3]

Barst RJ, 2012, EUR HEART J, V33, P979

[4] A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension [J].

Barst, Robyn J. ;

Ivy, D. Dunbar ;

Gaitan, Guillermo ;

Szatmari, Andras ;

Rudzinski, Andrzej ;

Garcia, Alberto E. ;

Sastry, B. K. S. ;

Pulido, Tomas ;

Layton, Gary R. ;

Serdarevic-Pehar, Marjana ;

Wessel, David L. .

CIRCULATION, 2012, 125 (02) :324-334

[5]

Child Health Corporation of America, 2012, OWN HOSP

[6]

European Medicines Agency, EPAR SUMM PUBL REV

← 1 →